| Alpha-MSH | alpha-melanocyte stimulating hormone |
| 8-iso-PGF2α | 8-Iso-prostaglandin F2 alpha |
| 15d-PGJ2 | 15-deoxy-Delta (12,14)-prostaglandin J2 |
| 15-PGDH | tumor suppressor 15-hydroxyprostaglandin dehydrogenase |
| 17β-HSD | 17β-hydroxysteroid dehydrogenase |
| 17-PT-PGE2 | 17-phenyltrinor-prostaglandin E2 |
| AA | arachidonic acid |
| AC | Adenylyl cyclase |
| ACSL3 | long-chain acyl-CoA synthetase |
| ACOX-1 | acilcoenzyme A peroxisomal A oxidase 1 |
| AH23848 | (4Z)-7-[(rel-1S, 2S, 5R)-5-((1,1′-Biphenyl-4-il) methoxy)-2-(4-morfolinil) 3-oxocyclopentil] |
| AIF | apoptosis inducer factor |
| AKR | aldo-keto reductase enzymes |
| AKR1C3 | aldo-keto reductase enzyme 1 C3 |
| AKT | protein kinase B (PKB) |
| ALL | acute lymphoblastic leukemia |
| AML | acute myeloid leukemia |
| AMPK | AMP-activated protein kinase |
| ASA | acetylsalicylic acid |
| AXAXB | protein 4 similar to BCL2 |
| BAX | BCL-2-like protein 4 |
| BAY11e7082 | NF-kB inhibitor |
| BCL2 | B-cell lymphoma 2 |
| BM | bone marrow |
| cAMP | cyclic adenosine monophosphate |
| cAMP-kinase A | cAMP-dependent protein kinase A (PKA) |
| Cd | Cadmium |
| cDc | classic dendritic cells |
| CD4 | cluster of differentiation 4 |
| CD45 | leukocyte common antigen |
| CD80 | cluster of differentiation 80 |
| CITED2 | cAMP-responsive element-binding protein (CBP) |
| COX1/2/3 | cyclooxygenase 1/2/3 |
| COXi | COX inhibitor |
| COXIB2 (celecoxib) | selective cyclooxygenase type 2 inhibitors |
| CREB | cAMP response element-binding |
| CRTC1 | transcriptional coactivator regulated by CREB1 |
| CUGBP1 | CUG triplet repeat, RNA binding protein 1 |
| CXCL8 | chemokine (C-X-C motif) ligand 8 |
| CYP2C | P450 arachidonic acid epoxygenase 2C |
| CYP4A | cytochrome P450 4A fatty acid omega hydroxylase |
| CYP2J | P450 arachidonic acid epoxygenase 2J |
| DAG | diacylglycerol |
| DAPS | 2.5-diacetyloxyphenylsulfonate |
| DC | Dendritic cells |
| DGLA | Dihomo-γ-linolenic acid |
| DHETE | dihydroxyeicosatrienoic acid |
| DMC | 2,5-dimethylcelecoxib |
| DP1 and DP2 | PGD2 receptors |
| DR5 | death receptor 5 |
| EET | epoxyeicosatrienoic acid |
| EGR1 | early growth response protein 1 |
| EGR3 | early growth response protein 3 |
| EMT | epithelial-to-mesenchymal transition |
| EP1, EP2, EP3 AND EP4 | PGE2 RECEPTORS |
| EPHA2 | Ephrin type-A receptor 2 |
| ER | ESTROGEN RECEPTOR |
| ERG | ETS-related gene |
| ERK1/2-MAPK | extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase |
| ETS | erythroblast transformation specific |
| FATP2 | Fatty acid transport protein 2 |
| FGF | fibroblast growth factor |
| FOXP3 | fork head box protein 3 |
| FP | PGF2a receptor |
| G | guanine nucleotide-binding protein |
| G12 | G protein that link cell surface G protein-coupled receptors primarily to guanine nucleotide exchange factors for the Rho small GTPases |
| Gi | G protein that transmits an inhibitory signal from membrane receptors to adenylyl cyclase |
| Gs | G protein that stimulates the cAMP-dependent pathway by activating adenylyl cyclase |
| Gq | G protein heterotrimeric that activates beta isoforms of phospholipase C |
| GTPase | guanosine triphosphatase |
| GW627368X | 4-(4,9-diethoxy-1,3-dihydro-1-oxo-2H-benz[f]isoindol-2-yl)-N-(phenylsulfonyl)-benzeneacetamide |
| HETE | hydroeicosateraenoic acids |
| HBV | hepatitis B virus |
| HCC | hepatocarcinoma |
| HO-1 | heme oxygenase 1 |
| Hypo-pRb1 | underphosphorylated retinoblastoma 1 |
| GRK2 | G-protein-coupled receptor kinase 2 |
| HPV | human papillomavirus |
| IFNγ | interferon gamma |
| IL-6 | Interleukin 6 |
| IL-1β | Interleukin 1β |
| IP | PGI2 receptor |
| IP6 | inositol hexaphosphate |
| IS | immune system |
| JNK | c-Jun N-terminal kinase |
| Ki-67 | nuclear protein related to cell proliferation |
| LKB1 | hepatic kinase B1. Serine-threonine kinase that directly phosphorylates and activates AMPK |
| LOX | Lipoxygenase |
| LPS | lipopolysaccharide |
| LPIAT1 | lysophosphatidylinositol-acyltransferase 1 |
| LTB | Leukotriene B |
| LXA | lipoxin A |
| MCL-1 | cell differentiation protein from induced myeloid leukemia |
| MCF-7 | Michigan Cancer Foundation-7 cell line |
| MDSC | myeloid-derived suppressor cells |
| MHC-II | major histocompatibility complex-II |
| miR-31-5p | microRNA-31-5p |
| miR-574-5p | microRNA-574-5p |
| M-MDSC | immature monocytic derived suppressor cells |
| MMP | cell matrix metalloprotease |
| MTII | Melanotan II |
| mTOR | muscular target of rapamycin |
| MYC | myelocytomatosis and tumor transcription factor |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NFκB | nuclear transcription factor kB |
| NK cells | natural Killer cells |
| NO | nitric oxide |
| NS-398 | nifluric acid |
| NSAIDs | nonsteroidal anti-inflammatory drugs |
| NSCLC | non-small-cell lung carcinoma |
| PARP | poly-ADP-ribose polymerase |
| Parthenolide | NF-kB inhibitor |
| PD-L1 | programmed death-ligand 1 |
| PET | positron emission tomography |
| pDC | plasmacytoid dendritic cells |
| PG | prostaglandin |
| PGD2 | prostaglandin D2 |
| PGDH | 15-hydroxy-prostaglandin dehydrogenase |
| PGE1 | prostaglandin E1 |
| PGE2 | prostaglandin E2 |
| PGE3 | prostaglandin E3 |
| mPGES-1 | microsomal PG synthetase 1 |
| PGES-1 | PG synthetase 1 |
| PGF2a | prostaglandin F-2α |
| PGF2β | prostaglandin F-2β |
| PGI2 | prostacyclin |
| PGIS | prostacyclin synthetase |
| PGM | PG urinary metabolite |
| PGT/SLCO2A1 | PG transporter |
| PGH2 | prostaglandin H2 |
| PI3K | phosphatidylinositol 3-kinase |
| PIP2 | phosphatidylinositol 4,5-bisphosphate |
| PIP3 | phosphatidylinositol (3,4,5)-trisphosphate |
| PKA-II | protein kinase A type 2 |
| PLC | phospholipase C |
| PMN-MDSC | granulocytic derived suppressor cells |
| PPARγ | peroxisome proliferator-activated receptor |
| PSA | PROSTATE ANTIGEN |
| PTEN | FOSFATIDILINOSITOL-3,4,5-TRISFOSFATO 3-FOSFATASA |
| PTGER4 | prostaglandin E receptor 4 [Homo sapiens (human)] |
| RGS10 | Regulator of G-protein signaling 10 |
| RHO | Ras homologous GTPase protein |
| ROS | reactive oxygen species |
| SC-236 | 4-[5-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide |
| SCLC | small-cell lung carcinoma |
| Se | selenium |
| sEH | soluble enzyme epoxide hydrolase |
| Snail | zinc finger transcriptional repressor |
| SND1 | staphylococcal nuclease domain containing 1 |
| SOX2 | sex-determining region of Y chromosome (SRY)-related high-mobility-group box 2 |
| SIK1/2 | salt-inducible kinases 1/2 |
| SRY | sex-determining region of Y chromosome |
| STAT3 | signal transducer and activator of transcription 3 |
| TDO | tryptophan 2,3-dioxygenase |
| TCF4 | transcription factor 4 |
| TMPRSS2 | (Transmembrane protease, serine 2) |
| TNFα | tumor necrosis factor Alpha |
| TNM stage | classification of malignant tumors and the extent of spread of cancer |
| TPA | tissue polypeptide antigen |
| TRAF2 | TNF receptor associated factor 2 |
| TRAIL | TNF-related apoptosis-inducing ligand |
| TXA | thromboxane A |
| TNF | tumor necrosis factor |
| XRCC5 | X-Ray Repair Cross Complementing 5 |
| uPAR | urokinase plasminogen activator surface receptor |
| UVB | ultraviolet radiation B |
| VEGF | vascular endothelium growth factor |
| YAP | Yes1 associated transcriptional regulator |
| ZEB1 | zinc finger E-box-binding homeobox 1 |
| ZIP | zinc Interacting Protein |
| ZBTB46 | zinc finger and BTB Domain Containing 46 |
| WNT | wingless and Int-1 |